“경산건마🚽 〔ØΡＤΑＬⓞ④ⓞㆍㄷΘм〕오피달리기 👧경산아로마👨경산휴게텔👈경산출장안마🏦경산아로마🌸경산키스방🙈경산OP🙄”的搜索结果，显示 231-240 项，共有 16931 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn., ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effects of Cognitive Function, Post-op Fatigue ... 4 weeks, and at 3-6 months) cognitive function ... Safety is defined as any acute grade 3 (CTCAE v5.0) or greater ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary purpose of this study is to standardize the collection of demographic, clinical, and imaging data, and biosamples for a large high-risk familial ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

6. 肝硬化- 症状与病因- 妙佑医疗国际

   除非病情变得相当严重，这种肝脏损伤即使进展到晚期，通常也不会出现任何症状。了解这种危及生命的肝脏病症的症状和治疗方法。

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...